Post by Biogen on X
Biogen@biogen
X#News: Today, we announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for an investigational therapy for spinal muscular atrophy (SMA). Learn more about this important milestone: t.co
16 likes1 repliesPosted Jun 4, 2026